Associations between fibrin D-dimer, markers of inflammation, incident self-reported mobility limitation, and all-cause mortality in older men

Journal of the American Geriatrics Society

Volumn 62, Issue 12, 2014, Pages 2357-2362

  Wannamethee, S Goya ^a   Whincup, Peter H ^b   Lennon, Lucy ^a   Papacosta, Olia ^a   Lowe, Gordon D ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

D dimer; inflammation; mobility limitation; mortality

Indexed keywords

C REACTIVE PROTEIN; D DIMER; FIBRINOGEN; INTERLEUKIN 6; FIBRIN DEGRADATION PRODUCT; FIBRIN FRAGMENT D;

AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; FOLLOW UP; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; QUESTIONNAIRE; SELF REPORT; SENESCENCE; WALKING DIFFICULTY; BLOOD; CAUSE OF DEATH; CLINICAL TRIAL; ENGLAND; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGY; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; RISK ASSESSMENT;

AGED; C-REACTIVE PROTEIN; CAUSE OF DEATH; ENGLAND; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HUMANS; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; MOBILITY LIMITATION; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVEYS AND QUESTIONNAIRES;

EID: 84918776299     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13133     Document Type: Article

References (30)

1. Singh T, Newman AB,. Inflammatory markers in population studies of ageing. Ageing Res Rev 2011; 10: 319-329.
2. Kerr R, Stirling D, Ludlam CA,. Interleukin-6 and hemostasis. Br J Haematol 2001; 115: 3-12.
3. Lowe GD,. Fibrin D-dimer and cardiovascular risk. Semin Vasc Med 2005; 5: 387-398.
4. Rao KM, Pieper CS, Currie MS, et al. Variability of plasma IL-6 and cross linked fibrin D-dimer over time in community dwelling elderly subjects. Am J Clin Pathol 1994; 102: 802-805.
5. Robson SC, Shephard EG, Kirsch RE,. Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-1 beta, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 1994; 86: 322-326.
6. Tita-Nwa F, Bos A, Adjei A, et al. Correlates of D-dimer in older persons. Aging Clin Exp Res 2010; 22: 20-23.
7. Emerging Risk Factors Collaboration, Kaptoge S, Di Angelantonio E, et al. C-reactive protein concentration and risk of coronary heart disease, stroke and mortality: An individual participant meta-analysis. Lancet 2010; 375: 132-140.
8. Fibrinogen Studies Collaboration. Plasma fibrinogen level and the risk of major cardiovascular and nonvascular mortality. JAMA 2005; 294: 1799-1809.
9. IL6R Genetics Consortium Emerging Risk Factors Collaboration, Sarwar N, Butterworth AS, et al. Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies. Lancet 2012; 379: 1205-1213.
10. Marenberg ME,. Inflammation and coagulation: Direct mediators of physical function in the elderly. Am J Med 2003; 114: 235-236.
11. Nuesch E, Dale CE, Amuzu A, et al. Inflammation, coagulation and risk of locomotor disability in elderly women: Findings from the British Women's Heart and Health Study. Eur J Epidemiol 2012; 27: 633-645.
12. Penninx BW, Kritchevsky SB, Newman AB, et al. Inflammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc 2004; 52: 1105-1113.
13. Cohen HJ, Harris T, Pieper CF,. Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly. Am J Med 2003; 114: 180-187.
14. McDermott MM, Ferrucci L, Liu K, et al. D-dimer and inflammatory markers as predictors of functional decline in men and women with and without peripheral arterial disease. J Am Geriatr Soc 2005; 53: 1688-1696.
15. Reuben DB, Cheh AI, Harris TB, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc 2002; 50: 638-644.
16. Cesari M, Kritchevsky SB, Nicklas B, et al. Oxidative damage, platelet activation and inflammation to predict mobility disability and mortality in older persons: Results from the health aging and body composition Study. J Gerontol A Biol Sci Med Sci 2012; 67A: 671-676.
17. Folsom AR, Delaney JAC, Lutsey PL, et al. Associations of factor VIIIc, D-dimer, and plasmin-antiplasmin with incident cardiovascular disease and all-cause mortality. Am J Hematol 2009; 84: 349-353.
18. Huffman KM, Pieper CF, Kraus VB, et al. Relations of a marker of endothelial activation (s-VCAM) to function and mortality in community-dwelling older adults. J Gerontol A Biol Sci Med Sci 2011; 12A: 1369-1375.
19. Di Castelnuovo A, de Curtis A, Costanzo S, et al. Association of D-dimer levels with all cause mortality in a healthy adult population: Findings from the MOLI-SANI Study. Haematologica 2013; 98: 1476-1480.
20. Clarke R, Emberson JR, Breeze E, et al. Biomarkers of inflammation predict both vascular and non-vascular mortality in older men. Eur Heart J 2008; 29: 800-809.
21. Schnabel RB, Yin X, Larson MG, et al. Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol 2013; 7: 1728-1733.
22. Lee JK, Bettencourt R, Brenner D, et al. Association between serum interleukin-6 concentrations and mortality in older adults: The Rancho Bernardo Study. PLoS One 2012; 7: e34218.
23. Shaper AG, Pocock SJ, Walker M, et al. British Regional Heart Study: Cardiovascular risk factors in middle aged men in 24 towns. BMJ 1981; 283: 179-186.
24. Cugno M, Mari D, Meroni PL, et al. Haemostatic and inflammatory biomarkers in advanced chronic heart failure: Role of oral anticoagulants and successful heart transplantation. Br J Haematol 2004; 126: 85-92.
25. Wannamethee SG, Lowe GDO, Whincup PH, et al. Physical activity and hemostatic and inflammatory variables in elderly men. Circulation 2002; 105: 1785-1790.
26. Wannamethee SG, Whincup PH, Shaper AG, et al. Circulating inflammatory and haemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost 2009; 7: 1605-1611.
27. Wannamethee SG, Ebrahim S, Papacosta O, et al. From a postal questionnaire of older men, healthy lifestyle factors reduced the onset of and may have increased recovery from mobility limitation. J Clin Epidemiol 2005; 58: 831-840.
28. Walker M, Shaper AG, Lennon L, et al. Twenty year follow-up of a cohort study based in general practices in 24 British towns. J Public Health Med 2000; 22: 479-485.
29. Kamapuru B, Ershler WB,. Inflammation coagulation and the pathway to frailty. Review. Am J Med 2009; 122: 605-613.
30. Patterson CC, Smith AE, Yarnell JWG, et al. The associations of interleukin-6 (IL-6) and downstream inflammatory markers with risk of cardiovascular disease: The Caerphilly Study. Atherosclerosis 2010; 209: 551-557.